組織マイクロアレイの市場規模、シェア、成長分析：手技別、技術別、エンドユーザー別、地域別 - 産業予測 2025～2032年

組織マイクロアレイの世界市場規模は、2023年に113億米ドルと評価され、2024年の124億5,000万米ドルから2032年には270億8,000万米ドルに成長し、予測期間（2025～2032年）のCAGRは10.2％で成長する見通しです。

組織マイクロアレイ市場は、創薬における役割の拡大や製薬・バイオテクノロジー業界における継続的な技術革新に牽引され、大きな成長を遂げています。がんの罹患率の上昇と、正確で費用対効果の高い診断への需要が、この市場をさらに前進させています。組織マイクロアレイテクノロジーは、複数の組織サンプルのハイスループット分析を可能にし、研究と臨床診断の両方に不可欠であることを証明しています。バイオマーカーの検証や研究室経費の削減などの利点が、医学研究や個別化医療開発における使用の増加に寄与しています。しかし、初期設定コストの高さ、質の高い組織サンプルへのアクセスの制限、複雑なデータ解釈、熟練した専門家の必要性などの課題が、特にリソースの限られた新興国市場での市場拡大を妨げる可能性があります。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 技術分析
• ケーススタディ

組織マイクロアレイ市場規模：手技別

• 市場概要
• 免疫組織化学
• 蛍光in situハイブリダイゼーション（FISH）
• インサイチューハイブリダイゼーション
• その他の手技の種類

組織マイクロアレイ市場規模：技術別

• 市場概要
• ポリメラーゼ連鎖反応（PCR）
• 次世代シーケンシング
• DNAマイクロアレイ
• その他の技術の種類

組織マイクロアレイ市場規模：エンドユーザー別

• 市場概要
• 製薬およびバイオテクノロジー企業
• 調査機関

組織マイクロアレイ市場規模

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022～2024年）

主要企業プロファイル

• OriGene Technologies
• ProteoGenex
• PREMIER Biosoft
• Biocompare
• US Biolab
• Arrayit Corporation
• Protein Biotechnologies
• BioCat GmbH
• SunLink Bioscience, Inc.
• Bio SB

結論と提言

Global Tissue Microarray Market size was valued at USD 11.3 billion in 2023 and is poised to grow from USD 12.45 billion in 2024 to USD 27.08 billion by 2032, growing at a CAGR of 10.2% during the forecast period (2025-2032).

The tissue microarray market is experiencing significant growth, driven by its expanding role in drug discovery and ongoing innovations in the pharmaceutical and biotech industries. The rising incidence of cancer, coupled with the demand for accurate and cost-effective diagnostics, further propels this market forward. Tissue microarray technology enables high-throughput analysis of multiple tissue samples, proving essential for both research and clinical diagnostics. Its advantages, including biomarker validation and cost reduction in laboratory expenses, contribute to its increasing use in medical research and personalized medicine development. However, challenges such as high initial setup costs, limited access to quality tissue samples, complex data interpretation, and the need for skilled professionals may impede market expansion, particularly in developing regions with limited resources.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Tissue Microarray market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Tissue Microarray Market Segments Analysis

Global Tissue Microarray Market is segmented by Procedure, Technology, End-User and region. Based on Procedure, the market is segmented into Immunohistochemistry, Fluorescence in situ hybridization (FISH), In Situ Hybridization and Other Procedure Types. Based on Technology, the market is segmented into Polymerase Chain Reaction (PCR), Next-Generation Sequencing, DNA Microarray and Other Technology Types. Based on End-User, the market is segmented into Pharmaceutical and Biotechnological Companies and Research Organizations. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Tissue Microarray Market

The Global Tissue Microarray market is significantly driven by the extensive use of tissue microarrays (TMAs) in drug development processes, enabling the simultaneous screening of numerous tissue samples. By facilitating scientists' observations of diverse tissue responses to innovative drug compounds, TMAs play a crucial role in expediting target validation and toxicity assessment. This capability for high-throughput analysis has solidified TMAs as essential tools in the quest to develop safer and more effective therapies, ultimately enhancing the drug discovery pipeline and improving patient outcomes. Thus, their integral function in research and development continues to propel market growth.

Restraints in the Global Tissue Microarray Market

The Global Tissue Microarray market faces significant constraints primarily due to the limited availability of well-preserved, diverse, and standardized tissue samples, which hampers the overall efficiency of microarray techniques. Inconsistent sample quality stemming from variability undermines the accuracy of results and slows down research advancements. This challenge is particularly acute in the context of rare diseases and underrepresented populations, where sourcing reproducible and high-quality tissue samples proves to be a substantial obstacle. The lack of reliable tissue sources directly impacts the reliability of findings and the pace of scientific progress in this field.

Market Trends of the Global Tissue Microarray Market

The Global Tissue Microarray market is poised for significant transformation, driven by the integration of AI and digital pathology technologies. Over the next few years, advancements in automated pattern recognition and predictive modeling will enhance tissue microarray analysis, enabling quicker and more accurate diagnostics. This shift will not only minimize reliance on manual interpretation but will also make tissue microarrays more accessible to smaller hospitals and laboratories, thereby increasing research scalability. As a result, the market is expected to witness a surge in demand, fostering innovation and expanding its applications across diverse biomedical research fields and clinical diagnostics.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Analysis
• Case Studies

Global Tissue Microarray Market Size by Procedure & CAGR (2025-2032)

• Market Overview
• Immunohistochemistry
• Fluorescence in situ hybridization (FISH)
• In Situ Hybridization
• Other Procedure Types

Global Tissue Microarray Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Polymerase Chain Reaction (PCR)
• Next-Generation Sequencing
• DNA Microarray
• Other Technology Types

Global Tissue Microarray Market Size by End-User & CAGR (2025-2032)

• Market Overview
• Pharmaceutical and Biotechnological Companies
• Research Organizations

Global Tissue Microarray Market Size & CAGR (2025-2032)

• North America (Procedure, Technology, End-User)
  • US
  • Canada
• Europe (Procedure, Technology, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Procedure, Technology, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Procedure, Technology, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Procedure, Technology, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• OriGene Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ProteoGenex
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PREMIER Biosoft
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biocompare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• US Biolab
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Arrayit Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Protein Biotechnologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioCat GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SunLink Bioscience, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio SB
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations